 |
 Australia
|
|
|
|
|
 |
Precedex is a relatively selective alpha 2 agonist. It is approved for sedation of initially intubated post-surgical patients in an intensive care setting. The use of Precedex by continuous infusion should not exceed 24 hours
Consumer Medicine Information (PDF links):
PRECEDEX
For further information refer to your doctor
|
|
|
Precedex® (dexmedetomidine HCI) is available in:
|
|
|
|
|